14Sep 2017
A recently published study by Dyer O has exposed major drawbacks in the fast tracking process of some drugs available to the American patients without any stringent clinical evidence of their benefits. Drugs that receive accelerated approvals from the US Food and Drug Administration (FDA) often rest on a flawed evidence base, says research that evaluated […]
